Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals develops treatments for neurodegenerative diseases, with its lead product RELYVRIO approved for ALS. The company focuses on innovative therapies that target multiple pathways, aiming to change outcomes for patients with limited options. Continued clinical expansion and regulatory progress drive investor interest. Chart
Dollar General Corporation (DG)
Dollar General operates a chain of discount retail stores offering everyday essentials at low prices. The company’s rural growth strategy, private label expansion, and store remodels fuel performance. Its strong market presence and focus on affordability continue to drive consistent foot traffic and sales growth. Chart